TRAIL and Nanotechnology in Cancer Treatment
Author Information
Author(s): Farooqi Ammad Ahmad, Turgambayeva Assiya, Kamalbekova Gulnara, Suleimenova Roza, Latypova Natalya, Ospanova Sholpan, Ospanova Dinara, Abdikadyr Zhanat, Zhussupov Sabit
Primary Institution: Institute of Biomedical and Genetic Engineering (IBGE), Islamabad, Pakistan
Hypothesis
Can nanotechnology improve the delivery and efficacy of TRAIL-based cancer therapies?
Conclusion
Nanotechnological approaches significantly enhance the delivery and effectiveness of TRAIL-based therapeutics in cancer treatment.
Supporting Evidence
- TRAIL has shown the ability to selectively target cancer cells while sparing normal cells.
- Nanotechnology has improved the bioavailability and delivery of TRAIL-based therapeutics.
- Encapsulation of TRAIL in nanoparticles allows for sustained release and improved stability.
- Combination therapies using TRAIL and chemotherapeutics have shown promise in overcoming resistance.
- Nanoparticle formulations have been effective in preclinical models of various cancers.
Takeaway
Scientists are using tiny particles to help a special cancer-fighting protein called TRAIL work better against tumors.
Methodology
This review summarizes various nanotechnological methods for delivering TRAIL-based therapeutics in cell culture and animal studies.
Limitations
The review does not provide specific experimental data or results from clinical trials.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website